Identifying genomic and developmental causes of adverse drug reactions in children.
about
Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infantsImpact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patientsChloramphenicol toxicity revisited: a 12-year-old patient with a brain abscess.Pediatric critical care: grand challenges for a glowing future.HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.Pharmacogenomics and adverse drug reactions in children.Optimization of pediatric rheumatology therapeutics.Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?Relevance of G-quadruplex structures to pharmacogenetics.Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.Pharmacogenomics and drug interactions. A specific journal
P2860
Q27024346-B0BD36FF-9896-4E94-9BE4-99ED0D272114Q28542785-764B2785-9EF0-497A-B1BF-DD0CFD90D45CQ33404180-6A43F303-3371-433C-9D26-3C0C6DFBB6C7Q33574742-45D3447B-6E62-45FB-A579-3983DF476B3EQ37341208-87703225-A1AF-41CC-8E40-EA9A3D3AF59AQ37719025-4DD78982-B620-464B-A6CC-BA1B41817F1FQ37991520-80EC5CD3-0F02-4790-9A81-0980D31179AFQ38180728-0D85C7F1-69F9-446C-B9F8-5173648C7147Q38238947-61782D7D-6642-4F78-90DD-0364A6E15D56Q42065104-6B3F029B-A0A6-4622-A9ED-35440D748D9AQ48717168-FFC697A9-76C4-4AA6-A802-38AA5D3582DDQ57994609-D70F27B7-63C2-491A-8855-C2432472EE95
P2860
Identifying genomic and developmental causes of adverse drug reactions in children.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identifying genomic and developmental causes of adverse drug reactions in children.
@ast
Identifying genomic and developmental causes of adverse drug reactions in children.
@en
Identifying genomic and developmental causes of adverse drug reactions in children.
@nl
type
label
Identifying genomic and developmental causes of adverse drug reactions in children.
@ast
Identifying genomic and developmental causes of adverse drug reactions in children.
@en
Identifying genomic and developmental causes of adverse drug reactions in children.
@nl
prefLabel
Identifying genomic and developmental causes of adverse drug reactions in children.
@ast
Identifying genomic and developmental causes of adverse drug reactions in children.
@en
Identifying genomic and developmental causes of adverse drug reactions in children.
@nl
P2860
P356
P1433
P1476
Identifying genomic and developmental causes of adverse drug reactions in children.
@en
P2093
J Steven Leeder
Mara L Becker
P2860
P304
P356
10.2217/PGS.10.146
P577
2010-11-01T00:00:00Z